- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aura Biosciences Inc (AURA)
Track today's live Aura Biosciences (AURA) share price, performance and key data on this page with our current NASDAQ:AURA stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Aura Biosciences share price on the NASDAQ exchange. Use the dropdown to switch exchange for the AURA share price, head to our technical summary section, which provides analysis on Aura Biosciences share price buy/sell indicators using real-time data (or discuss the Aura Biosciences (AURA) stock price today with other investors in the Aura Biosciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:AURA share price (ISIN: US05153U1079) to enhance your trading decisions with our free investment tools and resources.
What Is the Aura Biosciences Inc Share Price Today?
The Aura Biosciences share price today is 8.04.
What Is the Stock Symbol for Aura Biosciences Inc
The stock symbol (or 'ticker') for Aura Biosciences Inc is "AURA."
What Stock Exchange Does Aura Biosciences Inc Trade On?
Aura Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Aura Biosciences Inc a Good Stock to Buy?
Determining whether Aura Biosciences (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:AURA share price (ISIN: US05153U1079) to enhance your trading decisions with our free investment tools and resources.
What Is the Aura Biosciences Inc Share Price Today?
The Aura Biosciences share price today is 8.04.
What Is the Stock Symbol for Aura Biosciences Inc
The stock symbol (or 'ticker') for Aura Biosciences Inc is "AURA."
What Stock Exchange Does Aura Biosciences Inc Trade On?
Aura Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Aura Biosciences Inc a Good Stock to Buy?
Determining whether Aura Biosciences (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.31
8.20
52 wk Range
4.73
9.54
AURA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.318.20
52 wk Range
4.739.54
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AURA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
18.80
Upside
+133.83%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Form 8K Aura Biosciences Inc For: 11 August- Investing.com
Form DEF 14A AURA BIOSCIENCES For: 29 June- Investing.com
- Form 8K Aura Biosciences Inc For: 11 August
- Investing.com
Form 4 Aura Biosciences Inc For: 8 July- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.80
(+133.83% Upside)
Earnings
Latest Release
11/08/2026
EPS / Forecast
-0.48 / -0.41
Revenue / Forecast
-- / --
Compare AURA to Peers and Sector
Metrics to compare | AURA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAURAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.4x | −10.2x | −0.4x | |
PEG Ratio | −0.88 | 0.17 | 0.00 | |
Price/Book | 2.6x | 3.8x | 2.6x | |
Price / LTM Sales | - | 7,104.0x | 3.1x | |
Upside (Analyst Target) | 120.8% | 166.0% | 47.5% | |
Fair Value Upside | Unlock | −15.6% | 5.9% | Unlock |
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company’s proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Aura Biosciences (NASDAQ: AURA) Share Price Today?
The Aura Biosciences stock price today is 8.04 USD.
What Stock Exchange Does Aura Biosciences (AURA) Trade On?
Aura Biosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Aura Biosciences?
The stock symbol (also called a 'ticker') for Aura Biosciences is "AURA."
What Is the Current Aura Biosciences Market Capitalisation?
As of today, Aura Biosciences (NASDAQ: AURA) market cap is 833.79M USD.
What Is Aura Biosciences's (AURA) Earnings Per Share (TTM)?
The Aura Biosciences EPS is currently -1.74 (Trailing Twelve Months).
When Is the Next Aura Biosciences Earnings Date?
Aura Biosciences's next earnings report will be released on 05/11/2026.
Is AURA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Aura Biosciences moving averages and other technical indicators, the daily buy/sell signal for AURA stock is Strong Buy.
How Many Times Has Aura Biosciences Stock Split?
Aura Biosciences has split 0 times. (See the AURA stock split history page for full effective split date and price information.)
How Many Employees Does Aura Biosciences Have?
Aura Biosciences has 113 employees, based on their latest Companies House report.
What is the current trading status of Aura Biosciences (NASDAQ: AURA)?
As of 12/08/2026, Aura Biosciences (AURA) is trading at a share price of 8.04 USD, with a previous close of 7.70 USD. The stock has fluctuated within a day range of 7.31 USD to 8.20 USD, while its 52-week range spans from 4.73 USD to 9.54 USD.
What Is Aura Biosciences (AURA) Price Target According to Analysts?
The average 12-month price target for Aura Biosciences is 18.80 USD, with a high estimate of 24 USD and a low estimate of 15 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +133.83% Upside potential.
What Is the AURA Premarket Price?
AURA's last pre-market stock price is 7.56 USD. The pre-market share volume is 950.00, and the stock has decreased by -0.14, or -1.82%.
What Is the AURA After Hours Price?
AURA's last after hours stock price is 8.10 USD, the stock has decreased by 0.06, or 0.75%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.